Oh, H. J., Cho, M. S., Lee, J. W., Jang, P., Chung, N., Cho, B., & Kim, H. (2013). Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia. The Korean Pediatric Society.
Citação norma ChicagoOh, Hyun Jin, Mun Sung Cho, Jae Wook Lee, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho, and Hack-Ki Kim. Efficacy of Imatinib Mesylate-based Front-line Therapy in Pediatric Chronic Myelogenous Leukemia. The Korean Pediatric Society, 2013.
MLA citiranjeOh, Hyun Jin, et al. Efficacy of Imatinib Mesylate-based Front-line Therapy in Pediatric Chronic Myelogenous Leukemia. The Korean Pediatric Society, 2013.
Opozorilo: Ti citati niso vedno 100% točni.